Sign in

CIK 0001676725 · Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474268251
Phone
650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$985,397
in 1 filing, $985K under 10b5-1 plans

Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hata Yujiro S −$985K President and CEO sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2021-06-10 Hampton Malcolm Garret Director Grant or award · Stock Option (right to buy) +11,000 11,000
2021-06-07 Dillon Michael P. SVP, Chief Scientific Officer Option exercise +1,500 $6.92 $10K 100,289
2021-06-07 Dillon Michael P. SVP, Chief Scientific Officer Sale −1,500 $20.22 $30K 98,789
2021-06-07 Dillon Michael P. SVP, Chief Scientific Officer Option exercise · Stock Option (right to buy) −1,500 51,000
2021-05-28 Stone Paul A. SVP, Chief Financial Officer Grant or award +859 $11.36 $10K 13,803
2021-05-11 Dillon Michael P. SVP, Chief Scientific Officer Option exercise +5,000 $6.92 $35K 103,789
2021-05-11 Dillon Michael P. SVP, Chief Scientific Officer Sale −5,000 $20.22 $101K 98,789
2021-05-11 Dillon Michael P. SVP, Chief Scientific Officer Option exercise · Stock Option (right to buy) −5,000 52,500
2021-02-24 Dillon Michael P. SVP, Chief Scientific Officer Grant or award · Stock Option (right to buy) +80,000 80,000
2021-02-24 Lackner Mark SVP, Head of Biology Grant or award · Stock Option (right to buy) +45,000 45,000
2021-02-24 Throne Jason SVP, General Counsel Grant or award · Stock Option (right to buy) +52,500 52,500
2021-02-24 Hata Yujiro S President and CEO Grant or award · Stock Option (right to buy) +195,000 195,000
2021-02-24 Stone Paul A. SVP, Chief Financial Officer Grant or award · Stock Option (right to buy) +80,000 80,000
2021-02-12 Kelley Susan L. Director Grant or award · Stock Option (right to buy) +22,000 22,000
2021-02-12 Kelley Susan L. Director Grant or award · Stock Option (right to buy) +22,000 22,000
2021-02-10 Lackner Mark SVP, Head of Biology Option exercise +596 $6.98 $4K 596
2021-02-10 Lackner Mark SVP, Head of Biology Sale −596 $21.00 $13K 0
2021-02-10 Lackner Mark SVP, Head of Biology Option exercise · Stock Option (right to buy) −596 33,014
2021-02-09 Dillon Michael P. SVP, Chief Scientific Officer Option exercise +5,000 $6.92 $35K 103,789
2021-02-09 Dillon Michael P. SVP, Chief Scientific Officer Sale −5,000 $20.74 $104K 98,789

Page 12 of 19 · 370 trades